Results 231 to 240 of about 1,819,069 (310)

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

Arthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall, Cinthia Blat, Eric Roberts, Jean W. Liew, Katherine Wysham, Namrata Singh, Janna Friedly, Lianne S. Gensler, Gabriela Schmajuk, Jinoos Yazdany   +9 more
wiley   +1 more source

Sociodemographic and Health-Related Disparities in 24-Hr Movement Cycles Among Older Adult Women: The Study of Women's Health Across the Nation. [PDF]

J Aging Phys Act
Dooley EE, Winkles JF, Badon SE, Colvin A, Derby CA, Karvonen-Gutierrez CA, Kline CE, Lange-Maia BS, Swanson LM, Ylitalo KR, Pettee Gabriel K.   +10 more
europepmc   +1 more source

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease

Arthritis Care &Research, Accepted Article.
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo, Robert Fox, Katherine M. Hammitt, Julie Frantsve‐Hawley, Matthew C. Baker, Stamatina Danielides, Eduardo De Sousa, Brent P. Goodman, Jennifer K. King, Steven Mandel, Ghaith Noaiseh, Pantelis P. Pavlakis, George Sarka, R. Hal Scofield, Arun Varadhachary, Daniel J. Wallace, Matt Makara, Nancy Carteron, Steven Carsons, In collaboration with the Consensus Expert Panel (CEP) members   +19 more
wiley   +1 more source

Identifying regulatory outcomes of Non-interventional Post-Authorisation Safety Studies (PASS) in the European repository of studies using publicly available information. [PDF]

Front Drug Saf Regul
Almas MF, Girardi A, Crisafulli S, Gvozdanovic K, Hakkarainen KM, Hyeraci G, Hoogendoorn WE, Rillmann B, Roberto G, Vitturi G, Trifirò G, ENCePP WG3.   +11 more
europepmc   +1 more source

Diagnostic Utility of Testing for Novel Murine Autoantibodies for Sjögren's Disease in the Rheumatology Outpatient Setting

Arthritis Care &Research, Accepted Article.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren's disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr, Michael D. George, Vatinee Y. Bunya, Nora Sandorfi, Mina Massaro‐Giordano, Frederick B. Vivino   +5 more
wiley   +1 more source

Effects of participation in a large, online community for substance use disorder recovery: A naturalistic, longitudinal study. [PDF]

Psychol Addict Behav
Bergman BG, Boorman EP, Russell AM, Colditz JB, Kelly JF.   +4 more
europepmc   +1 more source

Minutes of the 83rd Meeting of the SPSC [PDF]

, 2007
JohnDainton,, Marcello Mannelli,
core